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Thymus  cells  and  bone marrow  cells  have  been  shown  to  interact  syner- 
gistically  in  the  humoral  immune  response  to  sheep  erythrocytes.  If  thymus 
and  bone marrow  cells  are  injected  together  into  heavily X-irradiated  hosts, 
there is approximately  a  10-fold  increase in  the  number  of  antibody-forming 
cells compared to that seen after injection of either thymus ceils or bone marrow 
cells alone (1,  2). Attempts to demonstrate such an interaction of thymus ceils 
and  bone  marrow  ceils  in  a  cellular  immune  response,  the  graft-versus-host 
reaction, have been unsuccessful  (3, 4).  However,  these experiments  involving 
the graft-versus-host reaction were carried out in unirradiated hosts, and there- 
fore are not strictly comparable to the sheep erythrocyte experiments,  in which 
hosts  received  at  least  650  R  X-irradiation  (1,  2).  In the unirradiated  host, 
functional  activities  of  injected  donor  ceils  may  be  masked  by  the  similar 
activities  of host cells,  and in the irradiated  host,  normal functional  activities 
of donor cells  may be  altered  by the  environment  which  promotes  rapid  re- 
generative  proliferation.  Therefore,  in  order  to  carry out experiments  on  the 
graft-versus-host  reaction which  would  be  comparable  to  those  involving  the 
humoral  immune  response,  we have  assessed  the  capacity of cell  suspensions 
from  thymus  and  bone marrow  to produce graft-versus-host  splenomega]y in 
X-irradiated  hosts.  We report  here  that  cell  suspensions  of thymus and bone 
marrow  interact  synergistically  in  the  production  of  graft-versus-host  sple- 
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nomegaly  in  X-irradiated  hosts.  The  mechanism  of  synergism  is  different 
however, in the production of splenomegaly than in the production of antibody 
to sheep erythrocytes. 
Materials and Methods 
Mice.--Highly inbred mice of the A and C57B1/1 strains and LAF1 mice resulting from the 
cross between these strains were used for these experiments. Young 7- to 10-day-old  mice of 
the LAF1 strain were used as recipients of cell injections. Donors of spleen and bone marrow 
cells suspensions were 45-  to 90-day-old A and LAF1 mice. Recipients were left with their 
mothers except during experimental manipulations. 
X-lrracliation. -X-irradiated animals (7-10 days of age)  were exposed to 300 or 500 R  24 
hr before cell injection. Irradiation factors were: 250 kvp, 15 ms, filters 0.5 ram Cu and 1 mm 
A1, half-value layer (HVL) 1.49 mm Cu, target skin distance (TSD) 40 inches, dose rate 27.8 
R  per min. No deaths occurred as a result of radiation exposure during the course of these 
experiments. 
Cell Suspensions.--Donor  mice were sacrificed  by cervical dislocation. Thymi were  surgi- 
cally removed, placed in Medium 199, sliced into six to eight pieces, and the cells gently dis- 
persed in a loosely fitting Potter-Elvehjem glass tissue homogenizer. The cell suspension was 
poured from the homogenizer into a Petri dish, and after passage of the suspension through 
a 25 gauge needle, the cells were counted and collected into 1 ml syringes for injection. Bone 
marrow suspensions  were prepared from donor femurs by the method of Ainsworth and Larsen 
(5). A small hole was made in the intercondylar fossa of the femur with a 25 gauge needle; 
the marrow was discharged through this hole by applying pressure to a needle inserted into the 
marrow cavity at the opposite end of the femur between the greater troehanter and the head. 
Medium 199 containing 0.5 unit of heparin per ml was used for marrow collection. After collec- 
tion, the marrow suspension was filtered through fine mesh nylon (pore size of 0.3 ram)  and 
the cells collected and counted. 
Assay  of Immunologic Compete~ce.--The graft-versus-host assay described by"  Simonsen 
et al.  (6)  was used. This assay measures splenic enlargement in F1 hybrid recipients of im- 
munologically competent cells from one parental strain. Since the F1 hybrid mice are geneti- 
cally tolerant of  cells  derived from either parental strain, a  host-versus-graft immunologic 
reaction is not a factor in the assay system. In a  non-immunologic sense, however, a  host- 
versus-graft reaction is present, since the splenomegaly is due  mostly to large  numbers of 
mononuclear cells  of host origin  (7,  8).  Strictly speaking, therefore, we are measuring the 
capacity of the donor cells to elicit a hyperplastic host response. 
The hosts were 7-10 day old LAF1 hybrid mice. For experiments in which cell suspensions 
from two sources were used, the cell suspensions were injected intraperitoneally, separately. 
Bone marrow cell suspensions were always administered within 90 rain after thymus or spleen 
cell suspensions. Intraperitoneal injections were performed under ether anesthesia. In the ex- 
periments involving host irradiation,  the irradiation was given 24  hr before cell  injection. 
8 days after injection of cell suspensions (9 days postirradiation in irradiation experiments), 
the animals were sacrificed,  their body and spleen weights measured, and the relative spleen 
weight (ratio of spleen weight to body weight) was determined for each animal. For experi- 
ments in which hosts received no X-irradiation, the spleen index was calculated for each in- 
jected animal by dividing its relative spleen weight by the mean relative spleen weight of 
non-injected littermate control animals. 
Several experimental results indicate that it is an immunologic attack by donor cells against 
the host which initiates the host splenomegaly response. For example, cells from donors im- 
munized against host antigens cause an increase in splenomegaly (9), and cells from donors 
tolerant of host antigens do not elicit splenomegaly (10). Lymphoid cells from donors which are HENRY R.  HILGARD  319 
genetically incapable of responding to host antigens do not elicit splenomegaly. Thymus cells, 
while possessing considerable  less immunologic competence  than cells from lymph node  or 
spleen, also elicit graft-versus-host splenomegaly  (11-13). As with lymphoid cells from other 
sources, thymus cell suspensions from an immune  animal elicit increased  splenomegaly in a 
host to which they are immune  (14). 
Experimental Plan.--Using the  graft-versus-host splenomegaly  assay as  described,  five 
categories  of experiments were performed: 
(a) Unirradiated LAF1 hosts were injected with parental strain thymus and/or parental 
strain bone marrow in an attempt to demonstrate an interaction of these cell populations. 
(b) Irradiated LAF1 hosts were injected with either parental strain spleen cells or syngeneic 
spleen cells to demonstrate the effect of host irradiation on the development  of graft-versus- 
host splenomegaly. 
(c) Irradiated LAF1 hosts were injected with parental strain spleen cells and syngeneic bone 
marrow cells in an attempt to reconstitute the graft-versus-host splenomegaly response. 
(d)  Irradiated LAF1 hosts were  injected with parental strain thymus and/or parental 
strain bone marrow in an attempt to demonstrate synergism in the production of graft-versus- 
host splenomegaly. 
(e) Irradiated LAF1 hosts were injected with syngeneic or parental strain thymus in addi- 
tion to either syngeneic or parental strain bone marrow in an attempt to dissect the immuno- 
logical aspects of the thymus-marrow synergism from the nonimmunological aspects. 
RESULTS 
Parental Strain  Thymus and Bone Marrow Cells Do Not Interact to Produce 
Splenomegaly in  Unirradiated  LAF1 Hosts.--In  order  to  determine  the  suit- 
ability of these LAF1 hybrids for estimation of splenomegaly produced by A 
strain thymus  cells, 40  >(  106, 20  )<  106, and  10  X  106  thymus cells from A 
strain donors were  injected into  7-10-day-old LAF1 hybrid recipients  (Table 
I). The spleen index results, obtained 8 days after injection, indicate that 40 >< 
106  cells produce  greater splenomegaly than  20  )<  106  cells (P  <  0.01),  and 
similarly that 20 X  106 cells produce greater splenomegaly than 10 )<  106 cells 
(P  <  0.05).  Thymus  cells from LAF1 donors  (40)<  106)  produce no spleno- 
megaly, ruling out  the possibility that nonspecific factors  associated with  the 
thymus cell suspension might contribute significantly to splenomegaly. 
To determine if an interaction could be demonstrated between thymus cells 
and bone marrow cells in unirradiated hosts, individual litters of at least eight 
animals were divided into four groups of at least two animals each and injected 
with cells from A  strain donors as follows: one group injected with 20  X  106 
thymus cells, one group injected with 20  )<  106 bone marrow cells, one group 
injected with  cells from both  sources,  and  one  group which was  not  injected 
with cells. The results, shown in Table II, indicate (a)  that bone marrow cells 
alone  do  not  exert  graft-versus-host  reactivity in  this  system,  and  (b)  that 
thymus  cells  and  bone  marrow  cells  together  elicit  the  same  amount  of 
splenomegaly that the thymus cells do when injected alone. 
Elimination of Graft-Versus-Host Splenomegaly by 500 R Host X-Irradiation.- 
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injected  24 hr later with  (a)  no cells,  (b)  10  X  108 spleen  cells from A  strain 
donors, or  (c)  10  X  106 spleen  cells from LAF1 donors.  Five or more mice of 
each group were sacrificed on various days following irradiation, and the relative 
spleen weights of the mice determined.  The results,  shown in Fig.  1,  indicate 
that by the second postirradiation  day there has been a  considerable decrease 
in  relative  spleen  weight  in  all  three  groups.  The  relative  spleen  weight  is 
increasing rapidly in the groups receiving irradiation  only, or irradiation plus 
syngeneic  spleen  cells  by  the  6th  postirradiation  day,  and  it  appears  that 
TABLE I 
Assay of Thymus Cells in Unirradiated LAFt Hosts 
No. of donor  No. of injected  Spleen index (=l=t SE) 
Donor strain  cells injected  hosts 
A  10 X  10 6  10  1.22  4- 0.086 
P  <  0.05 
A  20  X  106  10  1.45  4-  0.096 
P<  0.01 
A  40 X  106  15  1.87  4-  0,091 
LAFt  40 X  10 6  11  1.00  4- 0.025 
TABLE II 
Assay of Thymus Cells and Bone Marrow Cells from A Strain Donors in  Unirradiated LAF1 
Recipients 
Cell source  No. of cells injected  No. of hosts  Spleen  index (4-1  SE) 
Thymus  20 X  106  11  1.60  4- 0.186 
Bone marrow  20 X  106  11  1.04  4- 0.030 
Thymus and  20 X  106  12  1.61  -4- 0.115 
bone marrow  from each 
recovery is  slightly more rapid  in  the  group receiving syngeneic spleen  cells. 
In the group injected with 10 X  106 A strain spleen cells, however, in which a 
graft-versus-host  attack  is occurring,  there  is  a  relative  failure  of recovery of 
spleen weight,  and  in fact by the  9th  postirradiation  day the  relative  spleen 
weight in this group is only about half that of the other two groups. 
Graft-versus-host splenomegaly has  been shown  to be primarily  due  to the 
proliferation of host cells (7, 8). The absence of spleen weight recovery in these 
irradiated  mice undergoing a graft-versus-host reaction probably indicates that 
the host cell population is damaged to such an extent by the combined effects 
of irradiation  and  immune attack that host cell proliferation  cannot occur. If 
this  were  the  case,  unirradiated  cells  of host  ~enotype,  if  supplied  to  the  ir- HENRY  R.  HILGARD  321 
radiated  hosts,  might enable  the hosts  to  respond  to  the  immune  attack  with 
the  usual  splenomegaly.  We  therefore  supplied  bone  marrow  cells from  unir- 
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FIG.  I. Effect of  500R X-Irradiation  to  the  host on  graft-versus-host splenomegaly. 
[]  V], X-irradiation only. •  •,  X-irradiation and injection of 10 X  106 spleen cells 
from LAF1 donors.  ©  ©, X-irradiation and injection of 10  X  106 A strain spleen cells. 
Cell suspensions  were injected intraperitoneally 24 hr postirradiation.  (Bars at day 9 repre- 
sent +1 sE). 
TABLE III 
Graft-Versus-Host Splenomegaly in 500 R X-Irradiated LAF1 Hosts Injected with Syngeneic 
Bone Marrow* 
No. of spleen cells injected and  No. of LAFL bone  Mean relative spleen weight 
strain of spleen cell donor  marrow cells injected  No.  of hosts  of hosts (±1  SE) 
None  10 X  106  23  1.090  -4-  0.037 
10 X  106 LAF~  None  7  1.014  4-  0.084 
10 X  106 A  None  11  0.372  ±  0.018 
10 X  106 A  10 X  106  7  0.459  ±  0.069 
2 X  105 LAF1  None  10  0.996  ±  0.100 
2 X  105 A  None  9  1.065  4-  0.078 
2 X  105 A  10 X  106  14  1.436  ±  0.060 
* Hosts injected 24 hr postirradiation with spleen cells and/or bone marrow cells. 
Reconstitution  by  LAF1  Bone  Marrow  Cells  of  the  Graft-Versus-Host  Sple- 
nomegaly  Responses  in  500  R  X-Irradiated  LAF1  Hosts.--Mice  receiving  500 
R  of X-irradiation  were injected  24 hr later  either with  2  X  105 or  10  X  106 
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cells, some of these hosts were given an additional injection of 10  X  10 s bone 
marrow cells from syngeneic LAF1 donors.  Both  injections were given by the 
intraperitoneal route.  The  mice  were  sacrificed 8  days  after  cell  injection  (9 
days  postirradiation)  and  the  mean  relative spleen  weights  were  calculated. 
The  addition of bone marrow  cells did not  reconstitute  the splenomegaly re- 
sponse in  the hosts given 10  X  10 s A  strain spleen cells (Table III). On  the 
other  hand,  hybrid  bone  marrow,  injected  along  with  the  smaller  number 
(2)<  105) of A  strain spleen cells, produced significantly larger relative spleen 
weights than were seen in the groups receiving only marrow cells, or only spleen 
cells (P  <  0.01). 
TABLE IV 
Assay of Thymus Cells and~or Bone Marrow Cells in LAF1 Hosts Receiving 500 R X-Irradiation 
24 Hr Prior to Injection 
No. of cells  Strain of cell  No, of  Mean relative spleen 
Cell source  injected  donor  hosts  weight (4-1 SE) 
Thymus  20 X  106  LAF1  15  0.72  ±  0.052 
None  None  --  44  0.68  4- 0.042 
Thymus  20 X  106  A  19  0.76  4-  0.072 
P  <0.01 
Thymus  40 X  106  A  12  0.49  4.  0.027 
Bone marrow  20 X  106  LAF1  16  1.05  4-  0.037 
Bone marrow  20 X  l0 s  A  16  1.16  4.  0.056 
Bone marrow  40 X  106  A  8  1.25  4-  0.079 
P  <  0.001 
Thymus and  20 X  10 s  A  13  1.68  4-  0.052 
bone marrow  each 
From these results it is apparent that host strain bone marrow cells restore 
the  splenomegaly  response  if  the  graft-versus-host  reaction  is  initiated  by 
2  X  105 spleen cells, but not if it is initiated by 10 X  l0  s spleen cells. 
Synergistic Effecl of Parental Strain  Thymus  and Bone  Marrow Cells in  the 
Production  of  Splenomegaly  in  Irradiated  LAF1  Hosts.--Thymus  and  bone 
marrow cells were assessed in LAF1 mice receiving 500 R  X-irradiation. 24 hr 
postirradiation the mice were injected with thymus cells or bone marrow cells, 
or both, from adult A  strain donors.  The results are shown  in Table IV. The 
injection of 20  X  l0 s thymus  cells, whether  from A  or LAF1 donors, has  no 
significant effect on  the  relative spleen weight  in  comparison to  the  controls 
receiving  irradiation only.  However,  the  injection of 40  X  106  thymus  cells 
from A strain donors produces a depression of relative spleen weight, reminiscent 
of the similar depression obtained using spleen cells from A  strain donors.  If 
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increase in  relative spleen weight.  This  increase is not  graft-versus-host  sple- 
nomegaly, however, since F1 bone marrows cells, taken from donors syngeneic 
with the hosts, produce a  similar increase in relative spleen weight. 
When the LAF1 hosts were injected with both thymus cells and bone marrow 
cells from  A  strain  donors,  there  was  a  significant increase  (P  <  0.001)  in 
relative spleen weight  compared  to  that  obtained by  injection of  either  cell 
population alone. Cells from thymus and bone marrow thus act synergistically 
in the production of graft-versus-host splenomegaly in X-irradiated hosts. 
TABLE V 
Analysis of the Reactivity of 20 X  106 Thymus Cells and 20 X  106 Bone Marrow Cells Injected 
into 500 R X-Irradiated  LAF1 Recipients 
Strain of thymus  Strain  of bone  No. of  Relative  spleen  weights  Mean  spleen  index  rela- 
donor  marrOWdonor  hosts  of hosts (±1 SE)  tive to controlb°ne  marrow 
None  A  16  1.16  4- 0.056  1.00 
A  A  13  1.68  q- 0.052  1.45 
LAFt  A  12  1.22  4- 0.076  1.05 
None  LAFt  16  1.05  -4- 0.037  1.00 
A  LAFI  11  1.70  4-  0.096  1.62 
LAF1  LAFt  11  1.05  -4- 0.052  1.00 
TABLE VI 
Titration  of Thymus Cells from A  Strain Donors in 500 R  X-Irradiated  LAF1 Recipients of 
LAF1 Bone Marrow* 
No. of thymus cells injected  No. of hosts  Spleen index*  (=t=1 SE) 
1  X  105  9  1.08  ±  0.036 
2  X  105  11  1.28  -4- 0.066 
4  X  105  12  1.36  -4- 0.047 
8  X  105  10  1.47  -4- 0.062 
* Bone marrow  cells and thymus cells injected 24 hr post-irradiation. All mice received 
10 X  106 bone marrow cells. 
;~ Spleen  index calculated with respect to littermate controls receiving  irradiation and 
bone marrow, but no thymus cells. 
Marrow Contribution to the Thymus-Marrow Synergism Is Not Immunologic.- 
We next injected various combinations of thymus and bone marrow cells from 
A  and LAF1 donors in an attempt to separate the immune from the nonimmune 
components of the splenomegaly. Cells from LAF1 donors were employed since 
these cells obviously cannot mount an immunologic attack against the syngeneic 
LAF1 hosts. The results, shown in Table V, indicate that in order  to  obtain  a 
synergistic interaction, the thymus cells must be derived from A  strain donors. 
Therefore,  the thymus cells must react against the  allogeneic  antigens in  the 
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cells, on the other hand, may be from either A or LAF1 donors, and they there- 
fore perform a nonimmunologic function. 
If the thymus cells truly carry out an immunologic reaction in this synergism, 
then an increase in spleen index should be obtained by increasing the number 
of thymus  cells  injected  (12,  13).  We  therefore, injected various doses  of A 
strain thymus cells along with a standard dose (10 X  106) of LAF1 bone marrow 
cells into the 500 R X-irradiated hosts. The results, shown in Table VI, indicate 
that  the mean  spleen  index  (relative to  the  irradiated  control injected only 
with bone marrow) increases as the number of injected A strain thymus cells 
increases. 
DISCUSSION 
The results  of these experiments demonstrate that  thymus  cells and bone 
marrow  cells  must  both  be  injected  in  order  to  produce  graft-versus-host 
splenomegaly in  hosts  irradiated  with  500  R.  The  degree  of  splenomegaly, 
obtained by injecting both thymus and marrow cells from A strain donors into 
LAF1 hosts, greatly exceeds that obtained by injecting cells from either thymus 
or bone marrow alone. Evidence that the function of thymus cells in the pro- 
duction of  thymus-marrow splenomegaly is  immunologic is  provided by the 
finding that this splenomegaly is caused only by thymus cells which can mount 
an immunologic attack against the host. Further evidence of the immunologic 
function of the thymus cells is the finding that an increase in the number of 
thymus cells causes an increase in thymus-marrow splenomegaly. This is the 
relationship  expected for  immunologically competent  cells  exerting  a  graft- 
versus-host  reaction  (9,  12,  13).  The bone marrow  cells carry out  a  nonim- 
munologic function in this synergism, since marrow cells from F1 hybrids are 
just as effective as marrow cells from parental strain donors in the interaction 
with thymus cells. 
The interaction of thymus and bone marrow shown here represents a  true 
synergism, since the cooperative action of both cell populations is greater than 
the sum of the actions of the cell populations taken separately. It is important 
to note, however, that there is no synergism in the production of the  specific 
immune  response  itself:  thymus  cells  alone  are  responsible  for  the  immune 
attack in these experiments. The synergism applies only to splenomegaly, and 
splenomegaly in  turn depends upon a  nonimmunologic proliferative response 
which in these experiments is supplied by cells from the donor bone marrow. 
The thymus-marrow synergism shown here is thus not comparable in mech- 
anism to the synergism seen in the humoral immune response. In the humoral 
immune response to sheep erythrocytes, the bone marrow~derived cells produce 
specific antibody,  and  the  addition  of thymus  cells  facilitates this  antibody 
production by the marrow cells  (2,  15).  In this humoral  response, then,  cells 
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itself is produced; whereas in the production of graft-versus-host  splenomegaly 
the bone marrow cells add nothing to the immune attack which is carried out 
entirely by the thymus cells. 
Another line of evidence suggests that thymus cells function quite differently 
in reactions  of the graft-versus-host  type than  they do  in  humoral immune 
responses.  Experiments in which neonatally thymectomized mice have been 
reconstituted by injection of suspensions of allogeneic thymus cells show that 
the spleen cells from these reconstituted mice which possess  graft-versus-host 
reactivity have the histocompatibility characteristics of the donor thymus cells 
(16). On the other hand, spleen cells producing hemolysin to sheep erythrocytes 
from these mice have the histocompatibility characteristics of the host (17). 
Synergism in the production of graft-versus-host  splenomegaly by lymphoid 
cell populations from different sources has recently been reported by Cantor 
et al. (18),  but these authors do not report on thymus-marrow combinations. 
Their experiments which show,  for example, thymus-spleen and thymus-node 
synergism, were carried out in  (Balb/c  X  C57)F1 hosts which were injected 
with Balb/c or C57  cell populations. These authors suggest that specific  im- 
mune reactivity is needed on the part of both donor cell suspensions in order to 
elicit splenomegaly; however, their experiments concerning specificity may be 
unsatisfactory, since the hosts used for the specificity studies were pure bred 
C57 mice, in which synergisms were not demonstrated, whereas the synergistic 
interactions were all demonstrated in F1 hybrid hosts. No data are provided 
to indicate whether synergism could or could not have been demonstrated in 
the C57 hosts had they been injected with two cell populations competent to 
react immunologically against them. The situation in an F1 hybrid host, which 
cannot immunologically reject cells from either parental strain, is quite different 
from the situation in a C57 host, in which the genetic capability exists to reject 
either F1 hybrid cells or cells from another purebred strain. It is not ruled out, 
then,  that  one  or  the  other  cell  population in  their  experiments may have 
exerted its effect by contributing significantly to the host proliferative response. 
While  lymphoid  cells  might  well  interact  synergistically in  producing  the 
specific  immune response of graft-versus-host  attack,  this point seems not to 
have been established yet. 
Our failure to demonstrate an interaction of thymus and bone marrow in the 
production  of  splenomegaly  in  unirradiated  hosts  confirms  the  resuits  of 
Stutman and Good (3) and Davis et al. (4). Perhaps the interaction cannot be 
demonstrated in an unirradiated host because the proliferative response of the 
donor marrow cells is masked by the similar proliferative response which the 
host cells carry out. 
Also of interest is the finding that the spleen weight recovers very slowly after 
X-irradiation  in  recipients  of 40  X  106  parental  thymus cells  or  10  X  10 ~ 
parental spleen ceils. The explanation of this finding may be that the double 326  SYNERGISM  OF  THYMUS  AND  :BONE  MARROW 
insult of immune attack and X-irradiation has caused a greater impairment of 
the  proliferative capacity of host  cells than would  be  caused by irradiation 
alone. The graft-versus-host reaction may also prevent donor cells from func- 
tioning in the host (19, 20). Our experiments show that host strain bone marrow 
cells can reconstitute the splenomegaly response in irradiated recipients of small 
numbers  (2  X  105), but not larger numbers  (10  X  106), of attacking  spleen 
cells.  The failure of the bone marrow ceils to reconstitute the host response in 
recipients of 10 X  10  ~ cells may- be due to an inability of the marrow cells to 
colonize recipients in which the immunologic damage is great. 
The present experiments have revealed that the graft-versus-host response of 
splenoniegaly can be dissected  into  at least  two  component parts.  The first 
component is the immunologic attack, initiated in these experiments by thymus 
cells,  and  the  second  is  the host  proliferative response  to  the  immunologic 
attack. Irradiation has facilitated this dissection by causing a reduction in the 
host proliferative component, which we have reconstituted by injecting bone 
marrow cells. We have not identified the cell type from the bone marrow which 
restores the splenomegaly response to the irradiated host, but it seems likely 
that the macrophage population may be involved. It is known that macrophages 
are derived from bone marrow (21, 22), and it is also known that macrophage- 
like ceils,  derived from bone  marrow,  are  involved  in  reactions  of  delayed 
hypersensitivity providing a  necessary but immunologically nonspecific com- 
ponent of the reaction (23). 
Finally, it should be pointed out that there are problems associated with the 
use of the graft-versus-host assay to search for the interactions of donor cell 
populations. One problem is that the host supplies not only the environment 
for the donor cells, but also  the histocompatibility antigen to which the donor 
cells respond and the cells whose proliferative response must be assessed. Such 
complexity does not accompany the assessment of a humoral immune response 
to sheep erythrocytes carried out in  an irradiated host  (1,  2),  since the host 
here supplies only the environment for the donor cells,  not the antigen or the 
cells whose proliferation must be assessed. Furthermore, during a graft-versus- 
host  reaction,  cells  of donor  (graft)  genotype, including  hematopoietic stem 
cells (20), may be functionally impaired, possibly as a result of a  "bystander 
effect" in which cells which do not suffer from direct immune attack are none- 
theless damaged (24, 25). Therefore, the possibility cannot be completely ruled 
out  that  the presence of  an  ongoing graft-versus-host reaction has  somehow 
prevented  the  donor  marrow  cells from participating  in  a  specific  immune 
reaction which might otherwise have been demonstrable. 
SUMMARY 
Graft-versus-host splenomegaly may be elicited from 500  R  X-irradiated F1 
hybrid hosts if the hosts are injected with bone marrow cells and thymus cells HENRY  R.  ItILGARD  327 
from parental strain donors. Cells from thymus only or bone marrow only will 
not  elicit  graft-versus-host  splenomegaly  in  these  hosts.  In  this  requirement 
for  cells  from both  sources,  the  bone  marrow  cells  play  a  nonimmunoIogic, 
proliferative  role  in  the  splenomega]y,  and  the  thymus  cells  carry  out  the 
immunologic attack.  Thus  the mechanism of this  synergism is  quite different 
from that reported for the humoral immune response to sheep erythrocytes in 
which  both  thymus  and  marrow  interact  in  the  production  of  the  specific 
immunologic response itself. 
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